---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-23-000130"
form_type: "8-K/A"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T06:49:05.525126+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Pacific Biosciences appoints David Meline to Audit Committee

## Summary
- Board appointed David Meline to Audit Committee, effective October 24, 2023.
- Meline previously appointed as Class II director on October 13, 2023.
- Amendment No. 1 to Form 8-K adds committee assignment details.

## SEC filing metadata
- accession: 0001299130-23-000130
- form_type: 8-K/A
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913023000130/0001299130-23-000130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913023000130/pacb-20231013.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-23-000130
- JSON: https://secwatch.observer/filing/0001299130-23-000130.json
- Plain text: https://secwatch.observer/filing/0001299130-23-000130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.